Novel nail penetration enhancer containing vesicles “nPEVs” for treatment of onychomycosis

Abstract

Context: The systemic treatment of onychomycosis has been hampered by the reported side effects of antifungals in addition to the limited blood circulation to the affected nails. Topical ungual treatment would circumvent the limitations of systemic onychomycosis treatment. Objective: Preparation and characterization of nail penetration enhancer containing nanovesicles (nPEVs) loaded with sertaconazole for topical treatment of onychomycosis. Materials and methods: nPEVs were prepared using different nail penetration enhancers (N-acetyl-L-cysteine, thioglycolic acid, thiourea and ethanol) by the thin film hydration method, and characterized for their particle size, zeta potential, entrapment efficiency (EE%), elasticity, viscosity, physical stability and morphology. The selected nPEVs formula and the marketed Dermofix Õ cream were compared in terms of nail hydration, transungual drug uptake and antifungal activity against Trichophyton rubrum. Results: N-acetyl-L-cysteine was the optimum nail penetration enhancer for incorporation within vesicles. nPEVs showed high EE% of sertaconazole ranging from 77 to 95%, a size ranging from 38-538 nm and a zeta potential ranging from +48 to +72 mV. The selected nPEVs formula displayed spherical morphology and good storage stability. Compared to the conventional marketed cream, the selected nPEVs formula showed 1.4-folds higher hydration and drug uptake enhancement into nail clippings. Furthermore, it showed significantly higher zone of inhibition for Trichophyton rubrum (20.9 ± 0.25 mm) than the marketed cream (11.6 ± 0.44 mm). Conclusion: Nail penetration enhancer containing nanovesicles (nPEVs) present a very promising option, worthy of clinical experimentation on onychomycotic patients.

Intranasally administered in situ gelling nanocomposite system of dimenhydrinate: preparation, characterization and pharmacodynamic applicability in chemotherapy induced emesis model

“…They also increase the solubility of drugs, improve their bioavailability, provide a prolonged drug release and offer targeted drug delivery 1 . Penetration enhancer vesicles “PEVs”; which are composed of a penetration enhancer intermingled with phospholipids have recently presented themselves as a new versatile vesicular nanocarrier with wide variety of applications 2 – 7 ; namely for topical and transdermal delivery purposes. With the emergence of several functional materials that could be used in drug delivery, the term “nanocomposite” was introduced, which refers to a class of hybrid materials consisting of dissimilar components of different properties combined in one system 8 .…”

In vitro evaluation of the antifungal efficacy of poloxamer 407-based formulations in an infected nail plate model

“…However, it still remains a great challenge due to the low permeability of the nail plate, recurrence, fungal resistance and consequently low cure rates (Bseiso et al, 2015;Flores et al, 2015;Piérard et al, 1993).…”

Exploring the unique anticancer properties of curcumin nanoparticles

“…Owing to the surfactant and cosurfactant content of the microemulsion, it was reported to exhibit very small particle size. The negative charge exhibited by the microemulsion could be ascribed to the presence of ethanol and oleic acid [21,22]. Neither the particle size nor the charge was changed after 3 months storage, which indicated the stability of the microemulsion system.…”